Valuation: IRADIMED CORPORATION

Market Cap 111.18Cr 96Cr 90Cr 82Cr 154.22Cr 11TCr 156.36Cr 1.06TCr 413.66Cr 5.33TCr 417.43Cr 408.39Cr 18TCr P/E 2026 *
45.3x
P/E 2027 * 39.2x
Enterprise Value 111.18Cr 96Cr 90Cr 82Cr 154.22Cr 11TCr 156.36Cr 1.06TCr 413.66Cr 5.33TCr 417.43Cr 408.39Cr 18TCr EV / Sales 2026 *
12.2x
EV / Sales 2027 * 11x
Free-Float
64.81%
Yield 2026 *
-
Yield 2027 * -
1 day+1.23%
1 week-2.49%
Current month-3.13%
1 month-9.29%
3 months-0.54%
6 months-12.53%
Current year-9.52%
1 week 85
Extreme 85
92.7
1 month 85
Extreme 85
98.46
Current year 76.95
Extreme 76.95
107.9
1 year 67.84
Extreme 67.8421
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
30/03/26 Sell

Chief Executive Officer

7,500 0.0590%
13/02/26 Sell

Director

1,000 0.0079%
26/01/26 Sell

Chief Executive Officer

5,000 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%-2.49%+25.55%+81.00% 111.18Cr
-0.55%-4.22%-15.75%-19.85% 1.32TCr
+2.62%+3.59%+46.61%+15.69% 451.95Cr
-0.68%+1.08%-40.30%-52.24% 130.32Cr
-0.26%+23.61%-32.27% - 120.03Cr
+0.09%-1.04%-35.21%-37.62% 118.63Cr
-0.24%-4.44%+42.76%+144.25% 60Cr
-0.23%-3.52%+61.12% - 32Cr
-3.22%-2.10%-62.70%+272.60% 26Cr
+5.10%+17.72%+40.71%-0.99% 18Cr
Average +0.39%+2.51%+3.05%+50.35% 238.64Cr
Weighted average by Cap. +0.20%+0.47%-2.74%-2.53%

Financials

2026 *2027 *
Net sales 9.12Cr 7.87Cr 7.39Cr 6.73Cr 13Cr 871.99Cr 13Cr 87Cr 34Cr 436.87Cr 34Cr 33Cr 1.45TCr 10Cr 8.72Cr 8.18Cr 7.45Cr 14Cr 965.69Cr 14Cr 96Cr 38Cr 483.81Cr 38Cr 37Cr 1.61TCr
Net income 2.46Cr 2.13Cr 2Cr 1.82Cr 3.42Cr 235.69Cr 3.47Cr 23Cr 9.17Cr 118.08Cr 9.25Cr 9.05Cr 392.78Cr 2.84Cr 2.46Cr 2.3Cr 2.1Cr 3.95Cr 272.02Cr 4Cr 27Cr 11Cr 136.28Cr 11Cr 10Cr 453.33Cr
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
18/26/18 $88.02 +1.23% 1,06,372
14/26/14 $86.95 -0.24% 1,42,684
13/26/13 $87.16 -0.27% 90,088
12/26/12 $87.40 -1.73% 2,19,855
11/26/11 $88.94 -1.47% 1,84,276
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
86.95USD
Average target price
118.00USD
Spread / Average Target
+35.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock